Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and 2019 Novel Coronavirus Disease

zidovudine has been researched along with 2019 Novel Coronavirus Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Fridayantara, WD; Gedela, K; Irwanto, I; Luis, H; Rajus, N; Sukmaningrum, E; Wignall, FS1
Dong, Z; Wang, X; Yan, Q1
Augusto Chaves, O; Borba, NRR; Coutinho Souza, DD; da Rocha, JBT; da Rosa, RM; Dornelles, L; Ferreira, VNS; Mayer, JCP; Miranda, MD; Oliveira, TKF; Rocha, NS; Rodrigues, OED; Rosa, AS; Tucci, AR1
Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z1
Chien, M; Jockusch, S; Ju, J; Kalachikov, S; Kirchdoerfer, RN; Kumar, S; Li, X; Morozova, I; Russo, JJ; Tao, C1
Asiedu, E; Asiedu, SO; Kwarteng, A; Sakyi, SA1

Other Studies

6 other study(ies) available for zidovudine and 2019 Novel Coronavirus Disease

ArticleYear
Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
    HIV medicine, 2022, Volume: 23, Issue:9

    Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Communicable Disease Control; COVID-19; Female; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Indonesia; Male; Pandemics; Retrospective Studies; Sexual and Gender Minorities; Viral Load; Zidovudine

2022
The Variation of Transcriptomic Perturbations is Associated with the Development and Progression of Various Diseases.
    Disease markers, 2022, Volume: 2022

    Topics: Acquired Immunodeficiency Syndrome; COVID-19; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Stroke Volume; Transcriptome; Ventricular Function, Left; Zidovudine

2022
Antiviral Effect of 5'-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection.
    Molecules (Basel, Switzerland), 2023, Sep-19, Volume: 28, Issue:18

    Topics: Antiviral Agents; COVID-19; Humans; Molecular Docking Simulation; Papain; Peptide Hydrolases; RNA-Dependent RNA Polymerase; SARS-CoV-2; Selenium; Zidovudine

2023
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4
    AIDS research and therapy, 2020, 07-23, Volume: 17, Issue:1

    Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine

2020
Nucleotide analogues as inhibitors of SARS-CoV Polymerase.
    Pharmacology research & perspectives, 2020, Volume: 8, Issue:6

    Topics: Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Dideoxynucleotides; Drug Combinations; Heterocyclic Compounds, 4 or More Rings; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sofosbuvir; Thymine Nucleotides; Zidovudine

2020
Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 132

    Topics: Antiviral Agents; Computational Biology; Coronavirus Nucleocapsid Proteins; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Epitopes; Humans; Molecular Docking Simulation; Phosphoproteins; SARS-CoV-2; Viral Vaccines; Zidovudine

2020